Results 231 to 240 of about 20,100 (304)

Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome

open access: diamond, 2017
Ayşegül Oruç   +8 more
openalex   +1 more source

Complement in Antibody-Mediated Rejection of the Kidney Graft: From Pathophysiology to Clinical Practice. [PDF]

open access: yesJ Clin Med
Sorohan BM   +7 more
europepmc   +1 more source

Advances in the treatment of neuromyelitis optic spectrum disorder. [PDF]

open access: yesTher Adv Neurol Disord
Yang X, Zhang S, Feng J, Qin X.
europepmc   +1 more source

Marked clinical and jitter improvement after eculizumab in refractory myasthenia

open access: green, 2017
Vern C. Juel   +7 more
openalex   +2 more sources

Differential effects of C5 inhibition, C3 inhibition, and alternative pathway inhibition on bacterial killing in vitro. [PDF]

open access: yesBlood Adv
Ter Avest M   +6 more
europepmc   +1 more source

Complement factor H antibody-associated atypical hemolytic uremic syndrome and eculizumab treatment

open access: diamond, 2017
Zeynep Yürük Yıldırım   +5 more
openalex   +2 more sources

Macrophage activation syndrome successfully treated with eculizumab and emapalumab: a case report. [PDF]

open access: yesFront Immunol
Faggioli P   +10 more
europepmc   +1 more source

Atypical presentation of H1N1-induced thrombotic microangiopathy with CD46 gene mutation
. [PDF]

open access: yesClin Nephrol Case Stud
Pal A   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy